We are live on
!
Find out more
OAM
Oxford Asset Management Portfolio holdings
AUM
$232M
1-Year Est. Return
31%
This Fund
S&P 500
This Quarter
Est. Return
-10.3%
1 Year Est. Return
+31%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.85B
AUM Growth
-$949M
(-20%)
Cap. Flow
-$393M
Cap. Flow
% of AUM
-10.22%
Top 10 Holdings %
Top 10 Hldgs %
10.07%
Holding
2,323
New
652
Increased
471
Reduced
539
Closed
577
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATHN
Athenahealth, Inc.
ATHN
|
+$67.9M |
| 2 |
FSAC
Federal Street Acquisition Corp. Common Stock
FSAC
|
+$45.5M |
| 3 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$45.2M |
| 4 |
IDTI
Integrated Device Technology I
IDTI
|
+$34.6M |
| 5 |
NFX
Newfield Exploration
NFX
|
+$33.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$105M |
| 2 |
COL
Rockwell Collins
COL
|
+$84.8M |
| 3 |
CA
CA, Inc.
CA
|
+$72.4M |
| 4 |
ANDV
Andeavor
ANDV
|
+$52.9M |
| 5 |
PF
Pinnacle Foods, Inc.
PF
|
+$41.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.44% |
| 2 | Consumer Discretionary | 14.53% |
| 3 | Healthcare | 13.43% |
| 4 | Industrials | 13.16% |
| 5 | Financials | 12.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Genesco
GCO
$422M
| $2.75M | 0.07% |
62,108
-23,460
| -27% | -$1.01M |
|
327
Expedia Group
EXPE
$37.3B
| $2.75M | 0.07% |
+24,398
| New | +$2.92M |
|
328
Chemed
CHE
$7.22B
| $2.74M | 0.07% |
9,669
-714
| -7% | -$215K |
|
329
Veracyte
VCYT
$3.8B
| $2.74M | 0.07% |
217,568
+17,446
| +9% | +$206K |
|
330
Bruker
BRKR
$8.14B
| $2.73M | 0.07% |
91,880
-22,688
| -20% | -$716K |
|
331
HealthStream
HSTM
$840M
| $2.72M | 0.07% |
112,729
+37,910
| +51% | +$983K |
|
|
CSW
332
CSW Industrials
CSW
$5.71B
| $2.72M | 0.07% |
56,174
+22,348
| +66% | +$1.11M |
|
333
Target
TGT
$68B
| $2.71M | 0.07% |
40,978
-107,868
| -72% | -$8.3M |
|
|
B
334
Barrick Mining
B
$73.2B
| $2.71M | 0.07% |
+199,824
| New | +$2.58M |
|
|
CERN
335
DELISTED
Cerner Corp
CERN
| $2.71M | 0.07% |
51,611
-108,155
| -68% | -$6.27M |
|
|
MASI
336
DELISTED
Masimo
MASI
| $2.7M | 0.07% |
25,167
+4,487
| +22% | +$500K |
|
|
EGOV
337
DELISTED
NIC Inc
EGOV
| $2.69M | 0.07% |
215,895
-103,308
| -32% | -$1.38M |
|
338
Evertec
EVTC
$1.78B
| $2.69M | 0.07% |
93,795
-68,612
| -42% | -$1.8M |
|
|
TRCO
339
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
| $2.69M | 0.07% |
59,200
-354,059
| -86% | -$14.3M |
|
340
Kratos Defense & Security Solutions
KTOS
$11.4B
| $2.68M | 0.07% |
+190,102
| New | +$2.62M |
|
341
BJ's Restaurants
BJRI
$1.48B
| $2.68M | 0.07% |
+52,922
| New | +$3.19M |
|
|
PRFT
342
DELISTED
Perficient Inc
PRFT
| $2.67M | 0.07% |
120,136
+2,844
| +2% | +$69.8K |
|
343
Sprouts Farmers Market
SFM
$8.01B
| $2.65M | 0.07% |
112,870
+20,749
| +23% | +$540K |
|
344
Wintrust Financial
WTFC
$10.7B
| $2.65M | 0.07% |
39,915
+13,073
| +49% | +$993K |
|
|
FPRX
345
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.65M | 0.07% |
285,237
-11,102
| -4% | -$132K |
|
346
Cracker Barrel
CBRL
$1.29B
| $2.64M | 0.07% |
+16,533
| New | +$2.72M |
|
|
LOAC
347
DELISTED
Longevity Acquisition Corporation Ordinary Shares
LOAC
| $2.64M | 0.07% |
+265,000
| New | +$2.6M |
|
348
Insight Enterprises
NSIT
$4.38B
| $2.63M | 0.07% |
64,555
+24,730
| +62% | +$1.14M |
|
349
Rollins
ROL
$18.2B
| $2.63M | 0.07% |
+109,314
| New | +$2.82M |
|
350
VEON
VEON
$3.95B
| $2.63M | 0.07% |
+44,970
| New | +$3.04M |
|
Similar funds
KG
VOMP
TLA
RWS
SC
RWMG
TW
NTIC
Oxford Asset Management's Q4 2018 Portfolio in Review
As of Q4 2018, Oxford Asset Management held 2,323 positions worth $3.85B, down 20% from $4.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Oxford Asset Management withdrew a net $393M in Q4 2018, closing 577 positions and reducing 539 holdings. Its most notable exit was Envision Healthcare Holdings Inc, an estimated $105M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Oxford Asset Management opened a new position in Athenahealth, Inc. worth $69.9M.
- Oxford Asset Management's largest Q4 2018 buy was Athenahealth, Inc.: 530,000 shares worth $69.9M.
- Oxford Asset Management added most to Integrated Device Technology I in Q4 2018, an estimated $34.6M increase.
- Oxford Asset Management's biggest Q4 2018 reduction was GE Aerospace, cutting an estimated $18.1M.
- Oxford Asset Management fully exited Envision Healthcare Holdings Inc in Q4 2018, selling an estimated $105M.
- Oxford Asset Management's ten largest holdings make up 10% of its $3.85B portfolio in Q4 2018.
- Oxford Asset Management opened 652 new positions and closed 577 in Q4 2018.
- Oxford Asset Management's portfolio value fell 20% quarter-over-quarter to $3.85B.
Based on Oxford Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.